Critical vasospasm during fingolimod (FTY720) treatment in a patient with multiple sclerosis

Neurology. 2010 Jun 15;74(24):2022-4. doi: 10.1212/WNL.0b013e3181e3972b.

Authors

A Schwarz¹, M Korporal, W Hosch, R Max, B Wildemann

Affiliation

¹ Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.

PMID: 20548047
DOI: 10.1212/WNL.0b013e3181e3972b

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Arm / blood supply*
Blood Flow Velocity / drug effects
Blood Flow Velocity / physiology
Female
Fingolimod Hydrochloride
Humans
Multiple Sclerosis, Relapsing-Remitting / complications*
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Multiple Sclerosis, Relapsing-Remitting / physiopathology
Propylene Glycols / adverse effects*
Sphingosine / adverse effects
Sphingosine / analogs & derivatives*
Vascular Diseases / chemically induced*
Vascular Diseases / diagnosis*
Vascular Diseases / physiopathology

Substances

Propylene Glycols
Fingolimod Hydrochloride
Sphingosine